Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_assertion type Assertion NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_head.
- NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_assertion wasGeneratedBy ECO_0000203 NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_provenance.
- NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_assertion wasDerivedFrom befree-2016 NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_provenance.
- NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_assertion SIO_000772 18337602 NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_provenance.
- NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_assertion evidence source_evidence_literature NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_provenance.
- NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_assertion description "[Methylation of the promoter regions of p16 and CDH13 in both tumor and mediastinal lymph nodes was associated with an odds ratio of recurrent cancer of 15.50 in the original cohort and an odds ratio of 25.25 when the original cohort was combined with an independent validation cohort of 20 patients with stage I NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660338.RA1puu291xjp5el0VI8yqVqp6i9nVUjxuU0zt2Kt8kRhk130_provenance.